Association of Prooxidant-Antioxidant Balance with Clinical and Laboratory Parameters and Its Relation to Different Drug Regimens in Polycystic Ovary Syndrome Women with Normal BMI.

Heshmati, Niloofar; Shahgheibi, Shoaleh; Nikkhoo, Bahram; Amini, Sabrieh; Abdi, Mohammad

Heshmati, Niloofar; Shahgheibi, Shoaleh; Nikkhoo, Bahram; Amini, Sabrieh; Abdi, Mohammad.

Afiliação

Heshmati N; Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
Shahgheibi S; Department of Gynecology and Obstetrics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Nikkhoo B; Department of Pathology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Amini S; Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
Abdi M; Cellular and Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Indian J Clin Biochem ; 32(3): 315-322, 2017 Jul.

Article em En | MEDLINE | ID: mdl-28811691

Palavras-chave

Follicle stimulating hormone; Luteinizing hormone; Polycystic ovarian syndrome; Prooxidantantioxidant balance; Spironolactone; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google